InvestorsHub Logo
Followers 0
Posts 2177
Boards Moderated 0
Alias Born 04/13/2018

Re: None

Wednesday, 08/19/2020 11:47:12 AM

Wednesday, August 19, 2020 11:47:12 AM

Post# of 42786
Humanigen Out Of Position Once Again

With the hold on plasma treatment the need for some kind of therapy is higher than ever.

Except Humanigen forced into an extended Phase III study, lacking the results to even apply for a EUA, stands ready to be leap frogged by competition.

If they had any kind of efficacy, they would have had this up to the FDA and approved by now.

Explains why the share price is going down again. Just can't catch a break to save it's investors money.